Kitahara, Cari M.
Sosa, Julie A.
Article History
First Online: 7 September 2020
Competing interests
: J.A.S. is a member of the Data Monitoring Committee of the Medullary Thyroid Cancer Consortium Registry supported by GlaxoSmithKline, Novo Nordisk, AstraZeneca and Eli Lilly. J.A.S. receives institutional research funding from Exelixis and Eli Lilly. C.M.K. declares no competing interests.
Free to read: This content has been made available to all.